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Maintenance of cardiac structure andZ-disc signaling are key
factors responsible for protecting the heart in a setting of stress,
but how these processes are regulated is not well defined. We
recently demonstrated that PI3K(p110) protects the heart
against myocardial infarction. The aim of this study was to
determinewhether PI3K(p110) directly regulates components
of the Z-disc and cardiac structure. To address this question, a
unique three-dimensional virtual muscle model was applied to
gene expression data from transgenic mice with increased or
decreased PI3K(p110) activity under basal conditions
(sham) and in a setting of myocardial infarction to display the
location of structural proteins. Key findings from this analy-
sis were then validated experimentally. The three-dimen-
sional virtual muscle model visually highlighted reciprocally
regulated transcripts associated with PI3K activation that
encodedkey components of theZ-disc and costamere, including
melusin. Studies were performed to assess whether PI3K and
melusin interact in the heart. Here, we identify a novel melusin-
PI3K interaction that generates lipid kinase activity. The direct
impact of PI3K(p110) on myocyte structure was assessed by
treating neonatal rat ventricular myocytes with PI3K(p110)
inhibitors and examining the myofiber morphology of hearts
from PI3K transgenic mice. Results demonstrate that PI3K is
critical for myofiber maturation and Z-disc alignment. In sum-
mary, PI3K regulates the expression of genes essential for car-
diac structure and Z-disc signaling, interacts with melusin, and
is critical for Z-disc alignment.
An important question in cardiac biology is what makes one
heart stronger, ormore capable of resisting stress, than another.
Maintenance of cardiac structure and Z-disc signaling are con-
sidered key factors responsible for protecting the heart in a
setting of stress. Mutations of genes encoding proteins of the
costamere and Z-disc have been linked with cardiomyopathies
in animals and humans (1, 2). Costameres are specializedmem-
brane junctions that physically connect the Z-disc to the basal
lamina outside of the cell. The Z-disc is well recognized for its
role in maintaining structural integrity and, more recently, has
emerged as a “hot spot” or nodal hub of cardiomyocyte signal-
ing, converting mechanical signals into chemical signals, lead-
ing to a transcriptional response and induction of a cardiac
phenotype such as hypertrophy (1). Despite progress in this
area, themechanisms responsible for regulating components of
the costamere and Z-disc are not well defined (2).
The p110 isoform of phosphoinositide 3-kinase (PI3K-
(p110)/PIK3CA) has cardioprotective properties (3). We
recently demonstrated that cardiac expression of a constitu-
tively active (ca)3 PI3K transgene (increased PI3K activity) pro-
vided protection in a mouse model of myocardial infarction
(MI), whereas a reduction in cardiac PI3K activity (utilizing a
dominant negative (dn) PI3K transgene) accelerated the pro-
gression of heart failure (4). This makes targeting the PI3K
pathway an attractive approach for developing new treatment
strategies for heart failure.
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PI3K(p110) is a keymediator of insulin-like growth factor 1
(IGF1)-induced and exercise-induced beneficial physiological
cardiac hypertrophy (5). Unlike pathological hypertrophy/en-
largement, physiological cardiac hypertrophy is not an inde-
pendent predictor of cardiovascular mortality and has protec-
tive properties (3). IGF1 administered directly onto neonatal
cardiomyocytes in vitro increasedmRNAexpression and trans-
lation of contractile proteins, implicating a possible link
between activation of the IGF1-PI3K axis and regulation of the
expression of cardiac muscle structural components (6).
The primary aim of this study was to determine whether
PI3K(p110) specifically regulates cardiac structural compo-
nents. We hypothesized that regulation of cardiac structure by
PI3K(p110) may explain why caPI3K hearts are protected
against a cardiac insult, whereas dnPI3K hearts are more sus-
ceptible to heart failure. To address this question, we subjected
microarray data from PI3K transgenic mice under basal condi-
tions (sham) and in a setting of MI (4) to a recently developed
tool for visualizing changes in gene expression spatially across a
three-dimensional virtual muscle model (VMus3D) (7). The
VMus3D tool is a simple, fast approach that highlights differ-
ential expression of genes related to muscle structure, identify-
ing regulatory/structural relationships otherwise hidden from
more generalist mining approaches. Key findings from this
analysis were then validated experimentally.
EXPERIMENTAL PROCEDURES
Experimental Design—The VMus3D model (described
below) was applied to previously reported gene expression data
(4) (GEO accession number GSE 7487) from cardiac-specific
transgenic mouse models with increased or decreased PI3K
activity under basal conditions (sham) and in response to MI.
The experimental design encompassed a comparison of six
models that lie on a spectrum ranging from a physiological
“protective” model (i.e. caPI3K sham) to an accelerated heart
failure phenotype (i.e. dnPI3KMI). Such a design optimizes the
ability to accurately link molecular signatures with specific
phenotypes.
Themolecular phenotypes of the six groups are as follows: 1)
Non-transgenic (Ntg/control, FVB/N background) sham: Nor-
mal cardiac function and gene signature. 2) dnPI3K sham: Nor-
mal cardiac function at baseline, gene signature reflecting a
heart susceptible to stress. 3) caPI3K sham: Normal cardiac
function at baseline, physiological gene signature reflecting a
heart protected against stress. 4)NtgMI: Poor cardiac function,
heart failure/pathological gene signature. 5) dnPI3K MI: Very
poor cardiac function, gene signature reflecting accelerated
heart failure in comparison to Ntg MI. 6) caPI3K MI: Better
cardiac function than Ntg MI, a gene signature reflecting a
slowing of the heart failure process compared with Ntg MI.
VMus3D Modeling—Affymetrix probe set data generated
were normalized using the robust multiarray average method
(8, 9), then entered into VMus3D for visualizing gene expres-
sion changes in terms of location of their protein product in
muscle structure (further details are presented in the supple-
mental material and Ref. 7). Visualization was limited to genes
with p values  0.05 and colored using VMus3D according to
their significance and the direction of fold change being posi-
tive or negative. A two-by-two contingency table was con-
structed to compare reciprocally expressed genes observed
using VMus3D in sham and infarct settings. Significance was
assessed using the Barnard test and performed in R (10, 11).4
Gene lists were selected on the basis of the patterns recog-
nized using VMus3D, as described by criteria presented in the
supplemental material. The resulting lists were subjected to
gene set enrichment via DAVID (12).
Protein Analysis and Kinase Activity Assays—Heart lysates
were prepared as described (4). Western blot analysis: For
IGF1R, blots were probed with an anti-IGF1R  (Santa Cruz
Biotechnology, Inc., sc-713, 1:1000) followed by an anti-
GAPDH(SantaCruzBiotechnology, Inc., sc-32233,1:5000). For
Akt and ERK1/2, blots were probed with phospho-(Ser-
473)Akt (#9271), Akt (#9272), phospho-ERK1/2 (#9101) and
ERK1/2 (#9102) (all from Cell Signaling Technology, Inc.).
IRS1 Immunoprecipitation—Immunoprecipitation was per-
formed as described previously (13) using 1.5mg of heart lysate,
protein A-Sepharose, and an anti-IRS1 antibody (Millipore,
#06–248, 0.25 mg/ml). Blots were probed with the anti-IRS1
antibody (1:2000).
PI3K Activity/Lipid Kinase Activity—PI3K activity was
assessed inmouse ventricular tissue (13, 14). Heart tissue lysate
(1 mg) was immunoprecipitated with an anti-p85 antibody (0.5
l, Millipore, #06–195) or an anti-melusin antibody (5g) (15)
and subjected to an in vitro lipid kinase assay using phospha-
tidylinositol as a substrate. Part of the immunoprecipitated
enzyme was subjected toWestern blotting and probed with the
anti-p85 antibody (1:5000) and anti-melusin antibody (1
g/ml).
Interaction between the regulatory subunit of PI3K (p85) and
melusin—Heart lysate (5 mg) from wild-type, melusin-null
(16), and melusin-overexpressing mice (17) was immunopre-
cipitated with an anti-melusin antibody (15 g) (15) followed
by an immunoblot with an anti-p85 antibody (1:1000, Cell Sig-
naling Technology, Inc., #4257) and anti-melusin antibody (0.1
g/ml).
Cell Culture—Neonatal rat ventricular myocyte (NRVM)
culture was performed as reported previously (18) and
approved by an Institutional Animal Ethics Committee that
conforms with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals. NRVMwere treated with
two PI3K(p110) inhibitors (PIK75 (19) 0–100 M or A66 (20,
21) 0–50 M, both from Symansis, Auckland, New Zealand)
with and without IGF1 (10 nM, Novozymes Biopharma AU
Limited, CM001) for 18 h. Following experimental treatments,
cells were either collected for protein lysate isolation and
immunoblotting (18) or plated on laminin-coated glass cover-
slips and fixed in 4% paraformaldehyde for subsequent analysis
by immunofluorescence confocal microscopy (18).
Immunofluorescence Confocal Microscopy of NRVM and
Heart Sections—NRVM and heart sections (8 m) from PI3K
transgenic mice were analyzed by immunofluorescence stain-
ing with antibodies to -actinin (Sigma-Aldrich), phalloidin
(FITC-conjugates, Molecular Probes), DAPI, and Cy2/Cy3-
4 T. Galili, personal communication.
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conjugated secondary antibodies (Chemicon) as described pre-
viously (18, 22). Prior to staining, hearts from caPI3K, dnPI3K,
andNtgmicewere fixed inHistoChoice tissue fixative (Amer-
sco) for 4 h at 4 °C and then frozen in Tissue-Tek O.C.TTM
compound (Sakura Finetechnical).
Statistical Analysis—Statistical significance for gene expres-
sion data and VMus3D are described under “VMus3D Model-
ing” and in the supplemental data. Data from protein analysis
are presented as mean  S.E. Significance was determined
using one-way analysis of variance (p  0.05) followed by the
Fisher’s protected least significance post hoc test (p 0.05).
RESULTS
VMus3D Highlighted PI3K(p110)-regulated Transcripts
Encoding Key Components of the Costamere and Z-disc—We
reported previously that dnPI3K mice (cardiac PI3K activity
decreased by 77%) and caPI3K mice (cardiac PI3K activity
increased 6.5-fold) displayed normal cardiac function under
sham conditions but displayed distinct phenotypes in response
to MI for 8 weeks (4). In a setting of MI, caPI3K mice were
protected with better cardiac function than Ntg mice, whereas
dnPI3Kmiceweremore susceptible to heart failure progression
with poorer cardiac function than Ntg mice (4). VMus3D was
used to overlay gene expression data onto structural compo-
nents of cardiac muscle using data mined from Ntg and PI3K
transgenic mice under sham and MI settings (4) (Fig. 1). This
highlighted a distinct reciprocal pattern of gene expression
between the PI3K transgenic models under sham conditions
(Fig. 1C, blue, up-regulation in caPI3K; red, down-regulation in
dnPI3K; p  0.05), suggesting that PI3K activity can regulate
components of the costamere and Z-disc under basal condi-
tions. Thiswas consistentwith the hypothesis that PI3K activity
predisposes how the heart will respond to a subsequent cardiac
insult such as MI and prompted us to perform a reciprocal
expression analysis (dnPI3K versus caPI3K) across the full
microarray dataset.
Genes encoding muscle structural/associated proteins that
were differentially and reciprocally expressed in the PI3Kmod-
els under sham conditions included dystroglycan (Dag1), fil-
aminC (Flnc), ankyrin repeat domain 23 (Ankrd23/Darp), Rho-
associated coiled-coil containing protein kinase 2 (Rock2),
crystallin,  B (Cryab), Cd151, integrin  1 binding protein 2
(Itgb1bp2/melusin), Lim domain binding 3 (Ldb3/cypher), and
synaptopodin 2 (Synpo2/myopodin) (supplemental Equations
2 and 3 and Table I, p 0.05, Fig. 1). Each of these genes were
up-regulated in caPI3K (highlighted in blue, Fig. 1) and down-
regulated in dnPI3K (highlighted in red, Fig. 1) relative to Ntg.
Experimental Evidence for a Novel Interaction between
Melusin and PI3K in the Heart—Melusin (Itgb1bp2) is known
to interact with the cytoplasmic domain of 1-integrin, is
enriched in costameres, and has been shown previously to play
FIGURE 1.VMus3Dvisualizationof costamere andZ-disc gene expression. Schematicwith labeled components of the Z-disc (A) and costamere (B). A small
section of A (highlighted in gray) has been enlarged tomore readily identify individual components. Gene expression inmicewith increased PI3K (caPI3K) and
decreased PI3K (dnPI3K) under sham (C) andMI conditions (D) comparedwithNtg. The coloring indicates genes reciprocally expressed (p 0.05) according to
PI3K activity in the shammodel. Blue, positive fold change; yellow, no change; red, negative fold change.
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a critical role in sensingmechanical stress (16). The tail domain
of melusin is responsible for the interaction with 1-integrin,
whereas the amino-terminal portion of melusin has multiple
proline-rich motifs and tyrosine phosphorylation sites that
could bind to SH3- and SH2-containing proteins (23). Class IA
PI3Ks (including the p110 catalytic subunit) interact with
adaptor subunits containing SH2 domains, and the regulatory
subunit (85-kDa adaptor) contains an SH3 domain (24), sug-
gesting the possibility of an interaction between PI3K and
melusin. To assess whether PI3K and melusin interact in the
heart and the potential significance of such a complex, heart
tissue lysate was immunoprecipitated with an anti-melusin
antibody followed by an in vitro lipid kinase assay using PtdIns
as a substrate. Lipid kinase activity was observed in the heart
lysate immunoprecipitated with the anti-melusin or anti-p85
antibody (positive control) but not the negative control (Fig.
2A). To further validate an interaction between melusin and
PI3K in the heart, experiments in hearts from wild-type,
melusin-null, and melusin-overexpressing mice were per-
formed. Melusin-overexpressing mice allow melusin interac-
tors to bemore readily identified,whereas themelusin-nullmouse
is an ideal control for specificity. In the current study, the p85
regulatory subunit of PI3K was clearly detected in a melusin
immunoprecipitate obtained frommelusin-overexpressing trans-
genic mouse heart extracts (TG), and a weaker signal for p85 was
present in WT heart lysates. In contrast, no signal for p85 was
detected in heart lysates frommelusin-null mice (KO, Fig. 2B).
Enrichment of Genes Related to the IGF1 Pathway—To gain
further insight as to how PI3K might sense biomechanical
stress and regulate muscle structure and Z-disc signaling, we
performed a gene set enrichment analysis to investigate the global
effects of PI3K perturbation (supplemental Equation 3 and Table
II). Analysis against all “pathways” listed in DAVID identified the
following pathways (p  0.05): Ribosome (KEGG 0310), IGF1R
signaling (BIOCARTA), focal adhesion (KEGG04510), insulin sig-
naling (KEGG04910), IGF1 signaling (BIOCARTA), IL-2 receptor
 chain in T cell activation (BIOCARTA), and glycerophospho-
lipid metabolism (KEGG 00564). Enrichment of the IGF1-related
pathways was of particular interest, given that IGF1 plays an
important role in mediating cardiac protection (5), and
PI3K(p110) is a critical downstreammediator of IGF1R-induced
physiological heart growth (13).
By microarray, IGF1R and IRS1 mRNA expression were ele-
vated in hearts of Ntg in a setting of MI compared with sham
(Fig. 3A). IGF1R and IRS1 mRNA expression were lower in
caPI3K sham hearts and higher in dnPI3K sham hearts (Fig.
3A). IGF1R mRNA expression did not significantly increase in
caPI3K or dnPI3K mice in response to MI. To validate that
changes at the level of gene expression reflected protein levels,
we assessed IGF1R and IRS1 byWestern blotting and immuno-
precipitation, respectively. Consistentwith our gene expression
data, we observed parallel changes in protein expression of
IGF1R and IRS1 in the sham and MI models (Fig. 3, B and C).
Direct Evidence of an Impact of PI3K on Cardiac Myocyte
Structure—The VMus3D model and subsequent gene set
enrichment analysis suggested that IGF1-PI3K(p110) signal-
ing directly regulates cardiac myocyte structure. To test this
hypothesis, we performed two studies. 1) We assessed the
impact of two PI3K inhibitors on the myofiber structure in
NRVM and 2) examined the myofiber morphology of hearts
from Ntg, caPI3K, and dnPI3K under basal conditions.
1) Inhibition of PI3K(p110) prevents normal formation of
mature myofibers under basal conditions and in response to
IGF1: NRVM were treated independently with two
PI3K(p110) inhibitors (PIK75 and A66) in the presence or
absence of IGF1. PIK75 has been used previously to study the
role of PI3K(p110) but has some off-target activity (19, 25).
A66 is considered a more highly specific and selective inhibitor
for p110 (20, 21). The specificity of both inhibitors at different
doses (0.1–100M) was tested in NRVMwith or without IGF1.
The ratio of pAkt/total Akt was reduced by more than 50% in
IGF1 stimulated NRVM with 0.1 M PIK75 or 0.5 M A66 and
was abolished completely in IGF1-stimulated NRVM treated
with 1 M PIK75 or 10 M A66 (Fig. 4, A and B). The
PI3K(p110) inhibitors had no significant impact on pERK/
total ERK at these concentrations (Fig. 4, A and B). At substan-
tially higher concentrations of PIK75 (10 and 100 M), an
increase in ERK phosphorylation stimulated by IGF1 was not
FIGURE 2. Interaction between PI3K and melusin in the heart. A, heart
lysate was immunoprecipitated (IP) with anti-p85 antibody (lane 2, positive
control), anti-melusin antibody (lane 3), or no antibody (lane 1, negative con-
trol) and subjected to a lipid kinase assay using phosphatidyl inositol as a
substrate. PIP, PtdIns 3-phosphate represents PI3K activity. Part of the immu-
noprecipitate was subjected to Western blotting (IB) and probed with
anti-p85 or anti-melusin. B, heart lysate from WT, melusin-null (KO), and
melusin-overexpressing transgenic mice (TG) was immunoprecipitated with
anti-melusin antibody followed by immunoblotting with anti-p85 and anti-
melusin. Heart total extract (TE) was run as a reference for the molecular
weight of p85. Results were confirmed in four independent experiments.
Regulation of Cardiac Structure by PI3K(p110)
30840 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 35•SEPTEMBER 2, 2011
 at JA
M
ES CO
O
K
 U
N
IV
ERSITY
 (CAUL) on September 27, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
observed (Fig. 4A). A66 had no effect on pERK/total ERK, even
at 50 M (Fig. 4B).
Myofiber formation and sarcomere organization was exam-
ined by immunofluorescence. -actinin was used to highlight
the sarcomeric bands and Z-discs, and phalloidin was used to
stain the contractile actin thin filaments. Sarcomeres in the
control myocytes ran in multiple axes within the same cell and
were generally punctate and non-striated (Fig. 4, C and D,
dimethyl sulfoxide (DMSO)). Control cells also had an irregular
rounded morphology. In contrast, myocytes treated with the
PI3K(p110) inhibitors alone had an elongated stellate mor-
phology, and sarcomeres tended to run along a longitudinal axis
rather thanmultiple axes (Fig. 4, C andD, b and c, h and i, and t
and u). IGF1 stimulation resulted in an increase in NRVM size,
and this was associatedwith the formation ofmaturemyofibers
(increase in the organization of actin myofibrils as assessed by
phalloidin staining, with striated sarcomeres running in multi-
ple axes; Fig. 4,C andD, d, j, and v). The PI3K(p110) inhibitors
prevented the formation of mature myofibers in response to
IGF1 stimulation (Fig. 4, C and D, e, k, w, f, l, and x). Further,
A66 at 10 M was associated with a reduction in phalloidin
staining under basal conditions and in the presence of IGF1
(Fig. 4D, i and l).
2) Reduced Z-disc alignment in dnPI3K hearts: Myofiber
morphology was assessed in heart sections from adult Ntg,
dnPI3K, and caPI3K by immunofluorescence. There were
greater numbers of myofilaments and thicker myofibrils in
caPI3K hearts compared with Ntg hearts (Fig. 5). In contrast,
there were fewer myofilaments and thinner myofibrils in
dnPI3K hearts compared with Ntg hearts (Fig. 5). Z-disc align-
ment (-actinin stain) appeared reduced in dnPI3K hearts (Fig.
5). Phalloidin staining intensity of actin was markedly reduced
in sections from dnPI3K heart (Fig. 5) and is consistent with a
reduction in phalloidin staining observed in NRVM treated
with A66 (Fig. 4D).
DISCUSSION
The development of cardiomyopathy in humans and mouse
models with mutations/defects in Z-disc proteins highlight the
need to understand the molecular mechanisms that regulate
Z-disc biology (2). A greater knowledge of the basic mecha-
nisms responsible will be important for the development of
FIGURE 3. IGF1R and IRS1gene andprotein expression.A, IGF1R and IRS1 gene expression (log2) obtained bymicroarray. *, p 0.05 versusNtg sham; #, p
0.05 versus caPI3K sham. B, left panel, Western blot analysis of IGF1R andGAPDH in hearts fromNtg, caPI3K, anddnPI3Kmice subjected to sham (Sh) orMI. Right
panel, quantitative analysis of IGF1R relative to GAPDH. Mean values for Ntg Sh were normalized to 1. n 3 for Sh groups, n 4 for MI groups. *, p 0.0001
versusNtg Sh and caPI3K Sh; ˆ, p 0.001 versusNtgMI; §, p 0.001 versus caPI3KMI; #, p 0.01 versusNtgMI and caPI3KMI. C, left panel, immunoprecipitated
IRS1.Right panel, quantitative analysis of IRS1.Mean values forNtgwerenormalized to 1.n3 for eachgroup. *,p0.05 versusNtg Sh; ˆ,p0.05 versus caPI3K
Sh; #, p 0.05 versus caPI3K MI.
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improved therapeutic strategies for the heart. Z-disc proteins
share “sticky” domains that are capable of mediating multiple
protein-protein interactions and play an essential role in inte-
grating structure and signaling in the complex three-dimen-
sional network (2). Phosphatases and kinases, including cal-
cineurin and protein kinase C, have been shown previously to
reside at theZ-disc (2).However, whether PI3K(p110) directly
regulated cardiac structure and components of the Z-disc was
unknown. The goal of this study was to examine whether
PI3K(p110) regulates structural components of cardiac mus-
cle to protect the heart. We demonstrated previously that mice
with increased PI3K activity (caPI3K) develop physiological
cardiac hypertrophy, whereas mice with decreased PI3K activ-
ity have smaller hearts (14, 26). Cardiac function was normal in
both models under basal/sham conditions, but under settings
of stress (e.g. pressure overload, dilated cardiomyopathy, or
FIGURE4.NRVMtreatedwithPI3K(p110) inhibitors (PIK75orA66) in theabsenceandpresenceof IGF1.A andB,Westernblot analysesof pAkt, total Akt,
pERK, and ERK in cell lysates fromNRVM treatedwith or without IGF1 in the presence of PIK75 (0–100m) or A66 (0–50m). C andD, immunofluorescence of
control NRVM (dimethyl sulfoxide, DMSO) and NRVM treated with PIK75, A66, and/or IGF1 for 18 h. Anti- actinin (a–f) stains sarcomeric bands and Z-lines,
phalloidin-FITC (g–l) stains contractile thin filaments, and DAPI (m–r) stains nuclei. s–x, merged images. Scale bar 20 m. Experiments were repeated twice
with identical findings. Representative images from a single experiment are shown.
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MI), caPI3K mice were protected compared with Ntg, whereas
dnPI3K mice developed heart failure more rapidly (4, 26–28).
We hypothesized that applying the VMus3Dmodel to a robust
gene data set fromwell definedmodels (i.e. geneticmodels with
reciprocal regulation of PI3K in control (sham) and stress set-
tings (MI)) might enable us to uncover reciprocal expression
profiles of key elements of the Z-disc that predispose how the
heart responds to a subsequent cardiac insult such as MI.
FunctionalConsequences of Changes in PI3K-regulatedTran-
scripts Encoding Costamere and Z-disc Proteins—Under basal/
sham conditions, genes encoding muscle structural/associated
proteins that were up-regulated in hearts of caPI3K mice and
down-regulated in hearts of dnPI3K mice included dystrogly-
can (Dag1), filamin C (Flnc), ankyrin repeat domain 23
(Ankrd23/Darp), Rock2, crystallinB,Cd151,melusin, cypher,
and synaptopodin 2 (Synpo2,Myopodin) (Fig. 6). Thus, herewe
have observed a super-response ofmuscle structural/mechano-
sensors in mice with increased activity of PI3K(p110) i.e.
caPI3K. There is compelling evidence to demonstrate that
altered expression of many of these genes would have a signif-
icant impact on functionality of the Z-disc and, subsequently,
cardiac function. Dag1 links dystrophin to the extracellular
matrix. Cardiomyocyte-specific deletion of Dag1 in mice led to
dilated cardiomyopathy thatwas associatedwith depressed car-
FIGURE 5. Z-band alignment in myocytes from PI3K transgenic mice. Representative cross sections from ventricles of Ntg, caPI3K, and dnPI3K mice.
Anti-actinin (a–c) stains sarcomeric bands and Z-lines, phalloidin-FITC (d–f) stains contractile thin filaments, and DAPI (g–i) stains nuclei. j–l, merged images.
Scale bar 20 m. n 4 in each group.
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diac function (29). Flnc is a member of the filamin family,
expressed in heart and skeletal muscle (30). Filamins stabilize
actin filaments and link them to the cell membrane. Filamin
mutations in humans have been associated with muscle dys-
function (30). Furthermore, Flnc was identified as a substrate of
PI3K activatedAkt inmouse heart (31). Ankrd23 belongs to the
muscle ankyrin repeat protein (MARP) family and is a structur-
al/regulatory signaling protein that interacts with titin (32). In
skeletal muscle, the muscle ankyrin repeat protein family was
shown to be protective against eccentric contraction-induced
injury (33), suggesting that it plays an important role in main-
taining normal structure and function. Finally, cypher is a cyto-
skeletal protein localized in the sarcomeric Z-disc that was
shown to be essential for cardiac sarcomeric structure/stability.
Mice with cardiac-specific deletion of cypher or global cypher
knockout mice displayed severe cardiac defects and heart fail-
ure (34, 35).
Novel Interaction between PI3K and Melusin in the Adult
Heart—The reciprocal regulation of melusin in the caPI3K and
dnPI3K transgenic mice was of particular interest because
melusin-null (16) and melusin-overexpressing transgenic mice
(17) display similar phenotypes as dnPI3K and caPI3K trans-
genic mice, respectively. Both dnPI3K mice and melusin-null
mice displayed normal cardiac structure and function under
basal conditions but developed dilated cardiomyopathy in
response to pressure overload (16, 26, 27). In contrast, melusin-
overexpressing and caPI3K transgenic mice displayed a mild
physiological hypertrophic phenotype associated with an
increase inmyocyte size, Akt phosphorylation, and normal car-
diac function (14, 17, 27). Further, both models (melusin-over-
expressing and caPI3K transgenics) were protected in a setting
of pressure overload (17, 27). Collectively, these similarities
prompted us to assess whether PI3K and melusin form a com-
plex together in the heart. To our knowledge, we have shown
for the first time that the regulatory subunit of PI3K, i.e. p85,
directly interacts with melusin in the adult heart and generates
lipid kinase activity.
The IGF1-PI3K(p110) Pathway Is an Essential Regulator of
Cardiac Structure—Previous studies have demonstrated that
G-protein-coupled receptors, including the angiotensin II type
1 receptor, can sense biomechanical stress and regulate com-
ponents of the Z-disc (2). It has also been shown that cyclic
stretch of NRVM stimulated secretion of IGF1 (36) and that
treatment of NRVM with IGF1 increased mRNA expression
and translation of contractile proteins (6). It was previously
unclear whether the IGF1-PI3K(p110) axis played a critical
role in regulating components of the cardiac Z-disc. In this
study, a gene enrichment analysis highlighted overrepresenta-
tion of components of the IGF1 pathway. Gene and protein
expression levels of IGF1R and IRS1 were increased in hearts of
Ntg in a setting of MI compared with sham. Given that the
IGF1R pathway plays a critical role in mediating cardiac pro-
tection (5), we speculate that IGF1R and IRS1 increase in
response to stress (e.g. MI) as a mechanism for protecting the
heart. IGF1R and IRS1 expression levels were lower in caPI3K
sham hearts and higher in dnPI3K sham hearts. Further, any
FIGURE6.PI3K-regulatedcomponentsof thecostamereandZ-disc.Modelhighlightingcomponentsof thecostamereandZ-disc that are regulatedbyPI3K.
Expression of genes that were up-regulated in caPI3K hearts and down-regulated in dnPI3K hearts are highlighted in yellow. The model also highlights the
interaction between PI3K and melusin in the heart.
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increases in expression of IGF1R/IRS1 in a setting of MI were
smaller or absent in the PI3K transgenic mice. We hypothesize
that in a heart susceptible to stress (i.e. dnPI3K sham), the heart
attempts to compensate by increasing IGF1R signaling, but
because PI3K is a critical effector of the IGF1R pathway, the
dnPI3K transgene prevents an increase in structural compo-
nents and Z-disc signaling that would otherwise provide pro-
tection. By contrast, it is not necessary for IGF1R signaling to be
elevated in the caPI3K heart because structural components
are enhanced already. Our VMus3D model highlighted dis-
tinct reciprocal regulation of structural components of the
costamere and Z-disc that support this hypothesis, i.e. up-reg-
ulation in caPI3K and down-regulation in dnPI3K.
To ascertain whether PI3K(p110) had a direct impact on
cardiac structure, we used two independent approaches. First,
we examined the impact of two PI3K(p110) inhibitors on the
structure of NRVM under basal conditions and in the presence
of IGF1. Second, we examined the structure of cardiac sections
from caPI3K and dnPI3K mice in comparison to Ntg. Both
studies demonstrated that PI3K(p110) has an impact on
myofiber morphology and is critical for Z-disc alignment.
PI3K(p110) inhibitor-treated NRVM (without stimulation)
displayed sarcomeres that typically ran in a longitudinal axis
rather than multiple axes. IGF1 treatment was associated with
the formation of maturemyofibers, which was prevented in the
presence of the PI3K(p110) inhibitors. caPI3K hearts con-
tained greater numbers of myofilaments and thicker myofibrils
than Ntg, whereas dnPI3K hearts contained fewer myofila-
ments and thinner myofibrils. These findings are consistent
with the development of physiological hypertrophy in caPI3K
transgenic mice and the small heart phenotype of dnPI3K
transgenic mice (14). Z-disc alignment was reduced in dnPI3K
hearts, and phalloidin staining intensity of actin was markedly
reduced in sections from dnPI3K hearts. This finding is consis-
tent with reduced phalloidin staining of actin in NRVM pre-
treatedwithA66.Decreased phalloidin staining in dnPI3Kmice
is considered reflective of dysregulated sarcomeremorphology,
as opposed to these mice lacking actin filaments in their hearts,
because there was no evidence of differentially expressed genes
representative of the actin family in dnPI3K hearts. Collec-
tively, the above findings suggest a defect in myofibril forma-
tion and Z-disc alignment in myocytes with reduced PI3K
activity.
Targeting the PI3K Pathway with Caution: Heart Failure ver-
sus Cancer—Manipulating components of the PI3K pathway
has been recognized as themost active drug development in the
cancer field (37). PI3K is commonly constitutively activated
because of amutation inmany cancers (38). Our previous work
demonstrated that dnPI3K mice were more susceptible to the
development of atrial fibrillation and/or heart failure than con-
trol mice when exposed to pathological insults, including pres-
sure overload (26, 27), dilated cardiomyopathy (28), andMI (4).
These findings raise potential concerns for the effects of PI3K
inhibitors on the hearts of cancer patients. The very distinct
effects of PI3K activation on components of the costamere and
Z-disc under basal conditions (sham) in this study provide
important new insights as to why inhibition of PI3K makes the
heart susceptible to a cardiac insult and highlights that caution
must be taken when considering the administration of PI3K
inhibitors to patients.
In summary, understanding the very complex process of
mechanotransduction in cardiomyocytes is of utmost impor-
tance to our knowledge of how the heart responds in a setting of
stress and will be critical for the development of more effective
treatment strategies for heart failure. Herewe have used a novel
approach to visualize genes expressing proteins that form part
of the cardiac contractile apparatus that are regulated by PI3K.
To our knowledge, we have shown for the first time that PI3K
can directly affect components of the costamere and Z-disc,
PI3K complexes with melusin in the heart, and that PI3K has a
direct impact on cardiacmyofibermaturation and Z-disc align-
ment. Collectively, our data suggest that activation of PI3K is a
key mechanism that enables structural remodeling of the
costamere and Z-disc to protect the heart in a setting of stress.
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